Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy ICON Public Limited Company stock

Learn how to easily invest in ICON Public Limited Company stock.

ICON Public Limited Company is a diagnostics & research business based in the US. ICON Public Limited Company shares (ICLR) are listed on the NASDAQ and all prices are listed in US Dollars. ICON Public Limited Company employs 37,960 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in ICON Public Limited Company

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ICLR – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

ICON Public Limited Company stock price (NASDAQ: ICLR)

Use our graph to track the performance of ICLR stocks over time.

ICON Public Limited Company shares at a glance

Information last updated 2022-01-24.
Latest market close$250.39
52-week range$168.76 - $313.00
50-day moving average $281.73
200-day moving average $249.50
Wall St. target price$317.50
PE ratio 85.7264
Dividend yield N/A (0%)
Earnings per share (TTM) $2.94

Buy ICON Public Limited Company shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
M1 Finance
Free 1-year trial of M1 Plus
when you sign up for M1 Finance
Invest in your favorite stocks or in curated portfolios with automatic rebalancing.
SoFi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stash Invest
Stocks, ETFs
$1 per month
Add at least $5 to your Invest account
Stash is more than an investment app. You’ll have access to tools that can help you become a confident investor.
Stocks, ETFs, Cryptocurrency
$0 per month
Download and sign up with; approved accounts receive a free stock slice worth up to $300, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy ICON Public Limited Company stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

ICON Public Limited Company price performance over time

Historical closes compared with the close of $250.39 from 2022-01-25

1 week (2022-01-19) -2.59%
1 month (2021-12-23) -18.69%
3 months (2021-10-26) -12.19%
6 months (2021-07-26) 15.93%
1 year (2021-01-26) 17.50%
2 years (2020-01-24) 43.12%
3 years (2019-01-25) 84.65%
5 years (2017-01-26) 207.98%

Is ICON Public Limited Company stock undervalued or overvalued?

Valuing ICON Public Limited Company stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of ICON Public Limited Company's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

ICON Public Limited Company's P/E ratio

ICON Public Limited Company's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 86x. In other words, ICON Public Limited Company shares trade at around 86x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

ICON Public Limited Company's PEG ratio

ICON Public Limited Company's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.9428. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into ICON Public Limited Company's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

ICON Public Limited Company's EBITDA

ICON Public Limited Company's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $661.4 million.

The EBITDA is a measure of a ICON Public Limited Company's overall financial performance and is widely used to measure a its profitability.

ICON Public Limited Company financials

Revenue TTM $4.4 billion
Operating margin TTM 10.77%
Gross profit TTM $819.9 million
Return on assets TTM 2.83%
Return on equity TTM 3.68%
Profit margin 4.09%
Book value $97.90
Market capitalisation $20.1 billion

TTM: trailing 12 months

ICON Public Limited Company share dividends

We're not expecting ICON Public Limited Company to pay a dividend over the next 12 months.

Have ICON Public Limited Company's shares ever split?

ICON Public Limited Company's shares were split on a 2:1 basis on 12 August 2008. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your ICON Public Limited Company shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for ICON Public Limited Company shares which in turn could have impacted ICON Public Limited Company's share price.

ICON Public Limited Company share price volatility

Over the last 12 months, ICON Public Limited Company's shares have ranged in value from as little as $168.76 up to $313. A popular way to gauge a stock's volatility is its "beta".

ICLR.US volatility(beta: 0.89)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ICON Public Limited Company's is 0.8875. This would suggest that ICON Public Limited Company's shares are less volatile than average (for this exchange).

ICON Public Limited Company overview

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including product development planning, strategic consulting, study protocol preparation, clinical pharmacology, pharmacokinetic and pharmacodynamic analysis, site feasibility, patient recruitment and retention, digital patient and site, project management, clinical operations/monitoring, patient centric monitoring, data management, and adaptive and virtual trial services. The company's clinical development services also comprise medical imaging, biostatistics, medical affairs, pharmacovigilance, strategic regulatory, electronic endpoint adjudication, medical writing and publishing, interactive response technologies, functional solutions, strategic resourcing central laboratory, bioanalytical laboratory, biomarket development, strategy and analytics, late phase research, patient centered science, and medical device and diagnostics research services, as well as access, commercialization, and communication services, and research trials for us government agencies. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON has an agreement with Evergreen Therapeutics, Inc. to conduct Phase II clinical trial for COVID-19 drug candidate.

Frequently asked questions

What percentage of ICON Public Limited Company is owned by insiders or institutions?
Currently 0.754% of ICON Public Limited Company shares are held by insiders and 95.722% by institutions.
How many people work for ICON Public Limited Company?
Latest data suggests 37,960 work at ICON Public Limited Company.
When does the fiscal year end for ICON Public Limited Company?
ICON Public Limited Company's fiscal year ends in December.
Where is ICON Public Limited Company based?
ICON Public Limited Company's address is: South County Business Park, Dublin, Ireland, 18
What is ICON Public Limited Company's ISIN number?
ICON Public Limited Company's international securities identification number is: IE0005711209
What is ICON Public Limited Company's CUSIP number?
ICON Public Limited Company's Committee on Uniform Securities Identification Procedures number is: 289900102

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site